Revenue: The sum of all revenue fields included for a company's operating activities.
Mereo BioPharma Group plc - Sponsored ADR (MREO) had Revenue of $0.50M for the most recently reported fiscal quarter, ending 2025-06-30.
Income Statement Financials | |
Revenue |
$0.50M |
$-14.62M |
|
$0.13M |
|
$0.37M |
|
$11.00M |
|
$-10.50M |
|
$-4.12M |
|
$-14.62M |
|
$-14.62M |
|
$-14.62M |
|
$-14.62M |
|
$-14.62M |
|
$-14.62M |
|
$-10.50M |
|
$-10.34M |
|
159.89M |
|
159.89M |
|
$-0.09 |
|
$-0.09 |
|
Balance Sheet Financials | |
$61.42M |
|
$0.22M |
|
$1.21M |
|
$62.63M |
|
$7.56M |
|
-- |
|
$0.90M |
|
$8.45M |
|
$54.18M |
|
$53.71M |
|
$54.18M |
|
159.00M |
|
Cash Flow Statement Financials | |
$-15.98M |
|
$-0.32M |
|
$0.29M |
|
$69.80M |
|
$56.12M |
|
$-13.68M |
|
$4.34M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
8.13 |
|
-- |
|
-- |
|
-- |
|
-- |
|
73.60% |
|
-2099.80% |
|
-2099.80% |
|
-- |
|
-2923.20% |
|
-2923.20% |
|
$-16.00M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-26.98% |
|
-27.21% |
|
-23.34% |
|
-26.98% |
|
$0.34 |
|
$-0.10 |
|
$-0.10 |